Dr. Jarred Younger's good day/bad day study suggested that Leptin may be the inflammatory driver in chronic fatigue syndrome. Patients having bad days had elevated levels of leptin - and a network analysis suggested that leptin was the driver behind a major immune cascade.
Now a study finds high leptin levels in a subgroup of fibromyalgia patients with evidence of inflammation suggests some of them may have the same problem.
It's good news for everybody when research results start to cohere like this. It means multiple groups are looking in the same area...
In this nice overview of a study presented at a conference (but not yet published) this website states
Now a study finds high leptin levels in a subgroup of fibromyalgia patients with evidence of inflammation suggests some of them may have the same problem.
It's good news for everybody when research results start to cohere like this. It means multiple groups are looking in the same area...
They found that leptin seems to play an important pro-inflammatory and immunomodulatory role in the pathogenesis of this clinical subgroup of FM.
In this nice overview of a study presented at a conference (but not yet published) this website states
In this study, the research team used the Vectra®DA to measure serum biomarkers in patients with fibromyalgia and elevated inflammatory markers. This was a cross-sectional, prospective study of 33 patients from Los Angeles County. The average age of the patients was 43.5 years, with more females (94%) than males (6%). The patients met the 2010 ACR classification criteria for FM and had elevated ESR and/or C-reactive protein (CRP). The patients did not have clinical evidence of RA or other systemic rheumatic disease.
The results obtained with Vectra®DA were high in patients, with mean score of 46.5 (range 30 to 84, or moderate to high activity). The serum concentrations of the 12 biomarkers, such as IL-6 and CRP, except for leptin, were similar to the ones observed for RA patients. Among the FM patients, 45% had higher leptin levels, ranging from 30 to 81 ng/mL, than the ones reported in RA, ranging from 1 to 45 ng/mL. The FM patients had an average of leptin levels of 42.3 ng/mL. The CRP levels but not ESR was positively associated with the Vectra®DA score.
The researchers characterized a subgroup of FM patients with elevated ESR and/or CRP. The high Vectra®DA scores supported the idea of an inflammatory process associated to this subgroup of patients. In this subgroup the levels of leptin were higher, independent of body mass index (BMI), suggesting the influence of other variables besides obesity in this increase. They found that leptin seems to play an important pro-inflammatory and immunomodulatory role in the pathogenesis of this clinical subgroup of FM. Therefore, a better understanding of this clinical FM subgroup may lead to new diagnostic and therapeutic approaches in fibromyalgia.